
India · Medical devices startup
Sahajanand Medical Technologies (SMT) is a leading MedTech company based in India, specializing in the design, manufacture, and marketing of minimally invasive cardiovascular devices.
Funding reportedLast round: Secondary market
Follow Sahajanand Medical Technologies and see its new rounds in your feed.Start following
Sahajanand Medical Technologies (SMT) is a leading MedTech company based in India, specializing in the design, manufacture, and marketing of minimally invasive cardiovascular devices.
Their product range includes drug-eluting stents, structural heart therapies, and closure occluders for congenital defects. SMT is recognized as India’s first and largest stent manufacturer, holding a significant market share in the Indian drug-eluting stent market. Founded in 2001 and converted to a public limited company in 2021, SMT operates in over 80 countries, with headquarters in Mumbai and a manufacturing facility in Surat. The company is committed to providing clinically proven healthcare solutions, validated through rigorous clinical trials and featured in prominent medical journals. SMT serves healthcare professionals, including interventional cardiologists and surgeons, as well as patients with various heart conditions. With a focus on innovation and quality, SMT aims to enhance healthcare standards and improve patient outcomes globally.
Funding, as reported
What they build
Known for
peripheral interventionhealth caremedical innovationoccluder devicespercutaneous interventionsseptal occluderstavi devicescompetitive pricingdistributionmanufacturingtranscatheter aortic valvesclinical trial publications in the lancet and jaccsupraflex starpatient-centric solutionspatient care resourcesglobal healthcare market
Built with from their website
Google MapsGoogle Tag ManagerDHLFont AwesomeApacheYouTubeCloudFlareViewport MetaElement UIEcho
Microsoft ExcelFedExUPSMicrosoft ExchangeMicrosoft 365 Apps & ServicesMobile FriendlyBootstrapDrupal
Add your raise, your deck and your story, and put Sahajanand Medical Technologies in front of investors. Or tell us what we have wrong.